SMARCA4 and anaplastic large cell lymphoma: The suppression of BRG1 expression, achieved through the application of BRG1 inhibitors or siRNAs, led to a reduction in biological activities, including proliferation, survival, and migration, in anaplastic large-cell lymphoma cells.